This is an old revision of the document!

---

Vaccine type: Whole Virion Inactivated Corona Virus vaccine
Commercial name: COVAXIN®

EUL holder: Bharat Biotech International Limited
Country: India
URL: https://www.bharatbiotech.com/

WHO Recommended to Approve for Emergency Use License Effective date: 03 November 2021

Product Description
Route of administration: Intramuscular
Shelf-life: 9 months at storage temperature: 2 to 8°C
Age indication: Adults from 18 years of age

Preservative: phenoxy ethanol with concentration: 2.5 mg/dose

The phase 3 clinical trial results were published in the Lancet on November 11, 2021.
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial